Case Report

Journal of Artificial Organs

, Volume 16, Issue 3, pp 382-385

Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction

  • Don HayesJr.Affiliated withDepartment of Pediatrics, The Ohio State University College of Medicine, Nationwide Children’s Hospital Email author 
  • , Mark GalantowiczAffiliated withDepartment of Surgery, The Ohio State University College of Medicine, Nationwide Children’s Hospital
  • , Andrew R. YatesAffiliated withDepartment of Pediatrics, The Ohio State University College of Medicine, Nationwide Children’s Hospital
  • , Thomas J. PrestonAffiliated withDepartment of Cardiovascular Perfusion, Heart Center, Nationwide Children’s Hospital
  • , Heidi M. MansourAffiliated withDepartment of Pharmaceutical Sciences, University of Kentucky College of Pharmacy
  • , Patrick I. McConnellAffiliated withDepartment of Surgery, The Ohio State University College of Medicine, Nationwide Children’s Hospital

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.

Keywords

Cystic fibrosis Lung transplantation Venovenous extracorporeal membrane oxygenation Preventative Primary graft dysfunction Protective